iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 1-Year High – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as $105.15 and last traded at $104.90, with a volume of 14303 shares. The stock had previously closed at $103.08.

iShares U.S. Pharmaceuticals ETF Stock Performance

The business has a fifty day simple moving average of $99.43 and a 200 day simple moving average of $92.29. The stock has a market capitalization of $1.68 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

A number of institutional investors have recently modified their holdings of the business. EFG International AG bought a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth about $38,000. Assetmark Inc. increased its stake in iShares U.S. Pharmaceuticals ETF by 203.9% during the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after acquiring an additional 312 shares during the period. O Shaughnessy Asset Management LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 35.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after acquiring an additional 120 shares during the period. Blueline Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $41,000. Finally, Accent Capital Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $42,000.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.